ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?

Drug Deliv Transl Res. 2024 Jun;14(6):1660-1677. doi: 10.1007/s13346-023-01482-w. Epub 2023 Dec 12.

Abstract

The blood-brain barrier (BBB) poses a major obstacle in the treatment of all types of central nervous system (CNS) diseases. Small interfering RNA (siRNA) offers in principle a promising therapeutic approach by downregulating disease-related genes via RNA interference. However, the BBB is a formidable barrier for macromolecules such as nucleic acids. In an effort to develop a brain-targeted strategy for siRNA delivery systems formed by electrostatic interactions with cationic polymers (polyplexes (PXs)), we investigated the suitability of the well-known surfactant-based approach for Apolipoprotein E (ApoE)-functionalization of nanoparticles (NPs). The aim of this present work was to investigate if ApoE coating of siRNA PXs formed with cationic branched 25-kDa poly(ethyleneimine) (b-PEI) and nylon-3 polymers without or after precoating with polysorbate 80 (PS 80) would promote successful delivery across the BBB. We utilized highly hydrophobic NM0.2/CP0.8 nylon-3 polymers to evaluate the effects of hydrophobic cyclopentyl (CP) subunits on ApoE binding efficacy and observed successful ApoE binding with and without PS 80 precoating to the nylon-3 but not the PEI polyplexes. Accordingly, ApoE-coated nylon-3 polyplexes showed significantly increased uptake and gene silencing in U87 glioma cells but no benefit in vivo. In conclusion, further optimization of ApoE-functionalized polyplexes and more sophisticated in vitro models are required to achieve more successful in vitro-in vivo translation in future approaches.

Keywords: Apolipoprotein E; Brain targeting; Nylon-3 polymers; Polyethylenimine; Polyplexes; siRNA delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins E* / genetics
  • Blood-Brain Barrier* / metabolism
  • Brain / metabolism
  • Cell Line, Tumor
  • Humans
  • Mice
  • Nanoparticles* / administration & dosage
  • Nanoparticles* / chemistry
  • Polyethyleneimine* / administration & dosage
  • Polyethyleneimine* / chemistry
  • Polymers / administration & dosage
  • Polymers / chemistry
  • Polysorbates / chemistry
  • RNA, Small Interfering* / administration & dosage
  • RNA, Small Interfering* / chemistry

Substances

  • Apolipoproteins E
  • RNA, Small Interfering
  • Polyethyleneimine
  • Polymers
  • Polysorbates